Griffin Asset Management, Inc. Baxter International Inc Transaction History

Griffin Asset Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$76.85 - $89.45 $275,199 - $320,320	-3,581 Closed	0 $0
Q2 2021 Jul 28, 2021	SELL	$80.5 - $88.01 $9,579 - $10,473	-119 Reduced 3.22%	3,581 $288,000
Q1 2021 May 04, 2021	SELL	$76.38 - $86.03 $7,638 - $8,603	-100 Reduced 2.63%	3,700 $312,000
Q3 2020 Nov 12, 2020	SELL	$78.33 - $90.73 $2,114 - $2,449	-27 Reduced 0.71%	3,800 $306,000
Q1 2020 May 18, 2020	BUY	$71.57 - $93.3 $10,878 - $14,181	152 Added 4.14%	3,827 $311,000
Q1 2019 May 08, 2019	SELL	$64.48 - $81.31 $1,418 - $1,788	-22 Reduced 0.6%	3,675 $299,000
Q3 2018 Nov 19, 2018	SELL	$70.71 - $77.75 $5,515 - $6,064	-78 Reduced 2.07%	3,697 $285,000
Q2 2018 Aug 15, 2018	SELL	$63.43 - $75.41 $13,954 - $16,590	-220 Reduced 5.51%	3,775 $279,000
Q4 2017 Feb 20, 2018	SELL	$61.45 - $66.05 $153,625 - $165,125	-2,500 Reduced 38.49%	3,995 $258,000
Q3 2017 Nov 15, 2017	SELL	$59.5 - $64.61 $62,475 - $67,840	-1,050 Reduced 13.92%	6,495 $408,000
Q2 2017 Aug 29, 2017	BUY	N/A	7,545	7,545 $457,000

989

448M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.1B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Griffin Asset Management, Inc. with notifications on news.